---
title: "Heartflow says new press release is available on SCCT 2026 plaque analysis data"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292195506.md"
description: "Heartflow announced new press release data on SCCT 2026 plaque analysis. The update highlights eight presentations covering over 36,000 patients, demonstrating risk reclassification beyond coronary calcium scoring. A DECIDE Registry sub-study of 11,792 symptomatic patients showed that more than 50% with CAC 0 were reclassified into higher-risk categories using total plaque volume."
datetime: "2026-07-09T12:02:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292195506.md)
  - [en](https://longbridge.com/en/news/292195506.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292195506.md)
---

# Heartflow says new press release is available on SCCT 2026 plaque analysis data

-   Heartflow released a press announcement on Heartflow Plaque Staging, integrated into every Heartflow Plaque Analysis as a total plaque volume-based CAD staging tool. \* Update cites eight SCCT 2026 presentations spanning more than 36,000 patients, highlighting risk reclassification beyond coronary calcium scoring. \* DECIDE Registry sub-study of 11,792 symptomatic patients found more than 50% with CAC 0 moved into higher-risk categories using total plaque volume. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607090800PRIMZONEFULLFEED9759494) on July 09, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [HTFL.US](https://longbridge.com/en/quote/HTFL.US.md)

## Related News & Research

- [Humacyte says FDA accepts IND for first-in-human CTEV CABG study](https://longbridge.com/en/news/293928671.md)
- [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md)
- [Boardwalk REIT confirms annualized distribution of $1.8 per unit for September-November 2026](https://longbridge.com/en/news/294115240.md)
- [Hercules Capital declares Q2 2026 cash distribution of $0.47 per share](https://longbridge.com/en/news/294045773.md)
- [Seagate announces dividend of R$ 2.74 per unit for 3Q 2026](https://longbridge.com/en/news/294237647.md)